ALFRESA HOLDINGS
Alfresa Holdings engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. It operates through the following segments: Ethical Pharmaceuticals Wholesaling, Self-Medication Products Wholesaling, and Manufacturing. The Ethical Pharmaceuticals Wholesaling segment provides wholesale prescription drugs, medical diagnostic reagents, and medical devices, equipment, and materials to ... hospitals, clinics, dispensing pharmacies, and other institutions. The Self-Medication Products Wholesaling segment sells general over-the-counter drugs. The Manufacturing segment manufactures and markets products in the fields of pharmaceuticals, diagnostic reagents, and medical devices. The company was founded on September 29, 2003, and is headquartered in Tokyo, Japan.
ALFRESA HOLDINGS
Industry:
Biotechnology Health Care Manufacturing
Founded:
2003-09-29
Status:
Active
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Tag Manager Domain Not Resolving Apache Euro Microsoft Exchange Online
Current Employees Featured
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2016-04-30 | Sansho Co | Sansho Co acquired by Alfresa Holdings | N/A |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-05-14 | donut robotics | Alfresa Holdings investment in Venture Round - donut robotics | N/A |
2021-01-04 | Metcela | Alfresa Holdings investment in Series B - Metcela | 12.7 M USD |
2020-07-28 | Integrity Healthcare Japan | Alfresa Holdings investment in Corporate Round - Integrity Healthcare Japan | 500 M JPY |
2020-06-17 | PharmaBio | Alfresa Holdings investment in Corporate Round - PharmaBio | N/A |
2020-04-03 | Human Life CORD | Alfresa Holdings investment in Corporate Round - Human Life CORD | N/A |
2020-02-06 | Quantum Operation | Alfresa Holdings investment in Corporate Round - Quantum Operation | 300 M JPY |